Menu Search
Equities

Novartis AG

NOVNEE:SWX

Novartis AG

Actions
  • Price (CHF)0.00
  • Today's Change0.00 / --
  • Shares traded0.00
  • 1 Year change-100.00%
  • Beta--
Data delayed at least 15 minutes.
More ▼

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		NOVN:VTX since
announced		Transaction
value
Amblyotech IncDeal completed20 Apr 202020 Apr 2020Deal completed-11.38%--
The Medicines CoDeal completed24 Nov 201924 Nov 2019Deal completed-15.11%7.38bn
Data delayed at least 15 minutes, as of Aug 11 2020 16:36 BST.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Pyrford International Ltd.as of 30 Jun 2019265.81k0.00%
LUKB Expert Fondsleitung AGas of 31 Jan 202021.40k0.00%
Margetts Fund Management Ltd.as of 31 Jan 202016.27k0.00%
PPM America, Inc.as of 31 Dec 201912.05k0.00%
AQR Capital Management LLCas of 31 Mar 20205.54k0.00%
Niederer & Partners AGas of 30 Jun 20185.30k0.00%
NBG Asset Management MFMCas of 30 Jun 20193.93k0.00%
Sabadell Asset Management SA SGIIC Sociedad Unipersonalas of 31 Dec 20191.04k0.00%
Majedie Asset Management Ltd.as of 15 Nov 2019393.000.00%
CA Indosuez Wealth (Private Banking Europe)as of 30 Jun 2019361.000.00%
More ▼
Data from 30 Jun 2018 - 30 Jun 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.